Cagrilintide

Cagrilintide Unlike GLP-1 agonists (like Semaglutide), Cagrilintide acts as a dual agonist of the amylin and calcitonin receptors in the brain, offering a distinct pathway for hunger control. Studies show it reduces body weight by enhancing feelings of fullness. It is often paired with semaglutide (known as CagriSema) for superior weight loss. The combination of Cagrilintide and Semaglutide (CagriSema) has been shown to produce greater weight loss and better glycemic control than semaglutide alone.

Cagrilintide is a synthetic peptide supplied for qualified laboratory research use only. This material is intended for analytical characterization, assay development, method validation, and other non-clinical research applications conducted by properly trained professionals in controlled settings.

Product information is provided for compound identification and laboratory reference purposes only. Any use must be limited to lawful research activities and handled in accordance with applicable institutional, regulatory, and safety requirements.

RUO: This material is supplied strictly for research use only and is not intended for human or veterinary use, diagnostic use, therapeutic use, or food use.